{"title":"Phylogenetic analysis reveals genetic characteristics of orf virus F1L and B2L genes in the Fujian province.","authors":"Yusheng Lin, JinXiu Jiang, Yongliang Che","doi":"10.2460/ajvr.24.08.0222","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study investigates the molecular epidemiology of orf virus (ORFV) in the Fujian province in 2024, with the goal of gaining insights that can enhance disease prevention and control strategies.</p><p><strong>Methods: </strong>This experimental study was conducted from January 2024 through March 2024. The samples, showing suspected orf lesions, tested positive for ORFV via PCR. The ORFV059 (F1L) and ORFV011 (B2L) genes from these samples were cloned and sequenced.</p><p><strong>Results: </strong>Analysis identified 3 ORFV strains: FJ-2401, FJ-2402, and FJ-2403. For the F1L gene, nucleotide sequence identity ranged from 95.7% to 99.6%, and amino acid identity ranged from 95.0% to 99.7% compared to the reference strain. These strains were closely related to others from Fujian, Guangzhou, and India but differed from the NZ2 reference strain, the German D1701 weak strain, and Chinese vaccine strains, which were in separate branches. For the B2L gene, nucleotide identity ranged from 97.4% to 99.6%, and amino acid identity ranged from 97.1% to 100%. Evolutionary analysis indicated potential recombination events with strains from Fujian, Jilin, and India. The B2L gene showed distinct branching from the German D1701 weak strain, Fujian GO strain, and Chinese vaccine strains, suggesting that current vaccines might be inadequate.</p><p><strong>Conclusions: </strong>Viruses are constantly evolving, and currently available commercial vaccines may not provide sufficient protection against emerging ORFV strains. This underscores the urgent need for updated vaccines and improved management strategies.</p><p><strong>Clinical relevance: </strong>The study reveals significant genetic diversity and potential recombination in ORFV strains in Fujian, highlighting their divergence from known references.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":"1-7"},"PeriodicalIF":1.3000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of veterinary research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.2460/ajvr.24.08.0222","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study investigates the molecular epidemiology of orf virus (ORFV) in the Fujian province in 2024, with the goal of gaining insights that can enhance disease prevention and control strategies.
Methods: This experimental study was conducted from January 2024 through March 2024. The samples, showing suspected orf lesions, tested positive for ORFV via PCR. The ORFV059 (F1L) and ORFV011 (B2L) genes from these samples were cloned and sequenced.
Results: Analysis identified 3 ORFV strains: FJ-2401, FJ-2402, and FJ-2403. For the F1L gene, nucleotide sequence identity ranged from 95.7% to 99.6%, and amino acid identity ranged from 95.0% to 99.7% compared to the reference strain. These strains were closely related to others from Fujian, Guangzhou, and India but differed from the NZ2 reference strain, the German D1701 weak strain, and Chinese vaccine strains, which were in separate branches. For the B2L gene, nucleotide identity ranged from 97.4% to 99.6%, and amino acid identity ranged from 97.1% to 100%. Evolutionary analysis indicated potential recombination events with strains from Fujian, Jilin, and India. The B2L gene showed distinct branching from the German D1701 weak strain, Fujian GO strain, and Chinese vaccine strains, suggesting that current vaccines might be inadequate.
Conclusions: Viruses are constantly evolving, and currently available commercial vaccines may not provide sufficient protection against emerging ORFV strains. This underscores the urgent need for updated vaccines and improved management strategies.
Clinical relevance: The study reveals significant genetic diversity and potential recombination in ORFV strains in Fujian, highlighting their divergence from known references.
期刊介绍：
The American Journal of Veterinary Research supports the collaborative exchange of information between researchers and clinicians by publishing novel research findings that bridge the gulf between basic research and clinical practice or that help to translate laboratory research and preclinical studies to the development of clinical trials and clinical practice. The journal welcomes submission of high-quality original studies and review articles in a wide range of scientific fields, including anatomy, anesthesiology, animal welfare, behavior, epidemiology, genetics, heredity, infectious disease, molecular biology, oncology, pharmacology, pathogenic mechanisms, physiology, surgery, theriogenology, toxicology, and vaccinology. Species of interest include production animals, companion animals, equids, exotic animals, birds, reptiles, and wild and marine animals. Reports of laboratory animal studies and studies involving the use of animals as experimental models of human diseases are considered only when the study results are of demonstrable benefit to the species used in the research or to another species of veterinary interest. Other fields of interest or animals species are not necessarily excluded from consideration, but such reports must focus on novel research findings. Submitted papers must make an original and substantial contribution to the veterinary medicine knowledge base; preliminary studies are not appropriate.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
